OMNIAB, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
OMNIAB, INC. (OABI) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 5.00 million shares for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-09-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-09-23
- OMNIAB, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 5.00M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 5 month |
|---|---|---|
| 2021-06-30 | 5.00M shares 10-Q · filed 2021-09-23 | 5.00M shares 10-Q · filed 2021-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |